NIH-funded research R01 grant

Personalized colonoscopy schedule for people with Lynch syndrome

Official title: Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype

Funded at Columbia University Health Sciences · NIH-11167473 · Data updated 2026-11-12

This project aims to find colonoscopy schedules matched to each Lynch syndrome gene so people can avoid extra procedures while still preventing colorectal cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2021
Project endJuly 31, 2026
Funding year2025
Award (this year)$372,279
NIH project number5R01CA257333-05
Project IDNIH-11167473 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a confirmed Lynch syndrome pathogenic variant (for example MLH1, MSH2, MSH6, PMS2, or EPCAM) who are receiving or planning colorectal surveillance are the ideal candidates.

Less likely to help

People without a confirmed Lynch syndrome gene or those with complex prior colorectal cancer history or other medical reasons requiring individualized follow-up may not benefit from generalized genotype-based schedules.

What this research studies

You would hear how colorectal cancer risk differs depending on which Lynch syndrome gene you carry and see screening plans that reflect that risk. Researchers will combine medical records, cancer outcomes, and genetic information to model lifetime cancer risk and how often colonoscopies would be needed. They will compare harms and benefits like cancer cases prevented, deaths avoided, and the number of colonoscopies people would undergo. The goal is to suggest less frequent checks for lower-risk genes and focused surveillance for higher-risk genes so care is safer and easier to live with.

Why it matters

Potential benefit: If successful, this could lower the number of lifetime colonoscopies for many people with Lynch syndrome while maintaining strong protection against colorectal cancer.

How similar studies have gone: Previous research has documented different colorectal cancer risks by Lynch gene and modeling work supports genotype-tailored screening, but large prospective trials of personalized schedules are limited.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Hur, Chin — Columbia University Health Sciences
  • Study coordinator: Hur, Chin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.